Affinity Asset Advisors, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1773195
NEW YORK, NY
Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,099,082
+$2,957,107 QoQ
Shares Held
172,125
0.0% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#51
of 343 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Derivatives in PTGX
reported options exposure · as of Mar 31, 2025CallValue
$8,342,100
CallShares
172,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. PTGX ranks #27 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
3,750,000 | $132,712,500 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
987,000 | $131,004,510 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $113,561,516 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
1,595,000 | $96,274,200 | |
| 5 | ERAS |
Erasca, Inc.
|
5,250,000 | $96,180,000 | |
| 6 | INSM |
INSMED Inc
|
650,000 | $69,303,000 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
185,000 | $61,936,150 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
590,000 | $56,150,300 |
All Filings in PTGX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,099,082 | 172,125 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $18,141,975 | 172,125 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,033,397 | 172,125 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,654,458 | 220,600 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $24,318,800 | 440,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,342,100 | 172,500 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $19,344,000 | 400,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,018,000 | 130,000 | Shares | Sole | 2025-02-13 | |
| 2024-03-31 | $2,893,000 | 100,000 | Shares | Sole | 2024-05-14 | |
| 2022-03-31 | $5,112,512 | 215,900 | Put | Sole | 2022-05-13 | |
| 2022-03-31 | $7,104,000 | 300,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,246,269 | 241,119 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $6,287,688 | 140,100 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,295,000 | 50,000 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||